These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37874348)

  • 21. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
    Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
    Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma.
    Zeng H; Yang H; Song Y; Fang D; Chen L; Zhao Z; Wang C; Xie S
    Cell Death Dis; 2021 Nov; 12(11):1048. PubMed ID: 34741018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147.
    Yin Z; Cai H; Wang Z; Jiang Y
    Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel.
    Yan J; Shi L; Lin S; Li Y
    Bioengineered; 2021 Dec; 12(1):5334-5347. PubMed ID: 34415232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma.
    Chu J; Niu X; Chang J; Shao M; Peng L; Xi Y; Lin A; Wang C; Cui Q; Luo Y; Fan W; Chen Y; Sun Y; Guo W; Tan W; Lin D; Wu C
    Theranostics; 2020; 10(8):3488-3502. PubMed ID: 32206103
    [No Abstract]   [Full Text] [Related]  

  • 28. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
    Kang M; Ren M; Li Y; Fu Y; Deng M; Li C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):171. PubMed ID: 30049286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel target of esophageal squamous cell carcinoma: lncRNA GASL1 regulates cell migration, invasion and cell cycle stagnation by inactivating the Wnt3a/β-catenin signaling.
    Ren Y; Guo T; Xu J; Liu Y; Huang J
    Pathol Res Pract; 2021 Jan; 217():153289. PubMed ID: 33248356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
    Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
    Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2.
    Li J; Sang M; Zheng Y; Meng L; Gu L; Li Z; Liu F; Wu Y; Li W; Shan B
    Exp Cell Res; 2021 Dec; 409(1):112891. PubMed ID: 34688610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1.
    Pei Y; Wang P; Liu H; He F; Ming L
    Biomed Pharmacother; 2015 Aug; 74():89-94. PubMed ID: 26349968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remarkable inhibition effects of afatinib alone or combining with paclitaxel in esophageal squamous cell carcinoma.
    Yang LY; Cheng ZJ; Liu Z; Wang D; Zhang N; Fan ZL; Cai HQ; Zhang Y; Cai Y; Xu X; Wang JH; Du GH; Hao JJ; Wang MR
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2513-2522. PubMed ID: 33721913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
    Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
    Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.
    Huang S; Zhang J; He P; Cui X; Hou Y; Su W; Li F
    BMC Cancer; 2024 May; 24(1):557. PubMed ID: 38702629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of TRIM15 inhibits the proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inactivation of the Wnt/β-catenin signaling pathway.
    Zhang L; Qin B; Zou B; Wang S; Quan X; Wang J; Zhao H
    J Bioenerg Biomembr; 2021 Apr; 53(2):213-222. PubMed ID: 33515345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.